
Essling holds €100m first close for Essling Expansion
French GP Essling Capital has held a €100m first close for Essling Expansion fund, which targets a €250m final close in Q3 2019.
The fund, marketed since June last year, held the first close in December and recently completed its first transaction with Evolucare Group, a developer of medical software for healthcare institutions.
The private equity team of French asset management firm Massena span out and rebranded as Essling Capital in 2017. The new entity was set up and is owned by Massena founder Frank Noël-Vandenberghe and Michele Mezzarobba, who joined Massena in 2015 as a partner to head up the firm's non-listed activities.
Essling kicked off by managing co-investments, which are the minority transactions the team was specialised in when working at Massena. The GP held a final close for its second co-investment fund Essling Co-invest 2 on €116m in 2018. The vehicle aims to acquire minority stakes in LBOs over a 12-month period, investing between €10-30m per deal.
Essling subsequently expanded its activity to funds-of-funds as well as majority buyouts, recruiting professionals from existing teams and raising new funds, Unquote understands.
In 2017, it recruited the funds-of-funds team of limited partner Amundi Private Equity. Last year, Bertrand Fesneau and Rémi Matuchansky joined the firm as co-managers of Essling Expansion. They both worked for 3i and CM-CIC LBO Partners for 17 years.
Investors
Essling Expansion is currently backed by family offices, high-net-worth individuals and institutional investors, including regional banks including Caisses d’Epargne and pensions funds such as CARAC, ProBTP and SHAM.
LPs are mostly based in France but the GP expects to receive more commitments by European investors in the next phase of the vehicle’s fundraise.
Investments
Essling Expansion will target majority acquisitions or significant minority stakes. It intends to pursue domestic and international buy-and-build strategies.
The fund will invest in 10-12 fast-growing small and lower-mid-cap companies in the technology and healthcare sectors, providing equity tickets in the €10-40m range. Portfolio companies will typically have a €25-200m valuation.
People
Essling Capital - Bertrand Fesneau, Rémi Matuchansky (co-managers of Essling Expansion); Charles Bourgain (associate).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater